trial · primary record
Benralizumab
Eosinophilic Granulomatosis With Polyangiitis (EGPA)
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 14 |
| Primary completion | 2029-05-14 |
| Primary endpoint | Number of Participants with Adverse Events (AEs) |
| Registry ID | NCT06512883 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:39:32.990Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06512883
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- BENRALIZUMAB · approval
- Benralizumab · compound